(R)-1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(1-(2-chloroacetyl)pyrrolidin-3-yl)urea

ID: ALA5284090

Chembl Id: CHEMBL5284090

Max Phase: Preclinical

Molecular Formula: C14H14Cl2F3N3O2

Molecular Weight: 384.19

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N[C@@H]1CCN(C(=O)CCl)C1

Standard InChI:  InChI=1S/C14H14Cl2F3N3O2/c15-6-12(23)22-4-3-9(7-22)21-13(24)20-8-1-2-11(16)10(5-8)14(17,18)19/h1-2,5,9H,3-4,6-7H2,(H2,20,21,24)/t9-/m1/s1

Standard InChI Key:  YYGWWPOUHSJYKQ-SECBINFHSA-N

Alternative Forms

  1. Parent:

    ALA5284090

    ---

Associated Targets(Human)

NCI-H358 (882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.19Molecular Weight (Monoisotopic): 383.0415AlogP: 3.32#Rotatable Bonds: 3
Polar Surface Area: 61.44Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.32CX Basic pKa: CX LogP: 2.31CX LogD: 2.31
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.79Np Likeness Score: -2.31

References

1. Cheng R, Lv X, Bu H, Xu Q, Wu J, Xie K, Tang J, Wang L, Zhuang J, Zhang Y, Zhang Y, Yan C, Lai Y..  (2022)  Design, synthesis, and evaluation of 4(1H)-quinolinone and urea derivatives as KRASG12C inhibitors with potent antitumor activity against KRAS-mutant non-small cell lung cancer.,  244  [PMID:36228411] [10.1016/j.ejmech.2022.114808]

Source